Quarterly report pursuant to Section 13 or 15(d)

Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)

v3.3.1.900
Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)
3 Months Ended 12 Months Ended
Feb. 29, 2016
USD ($)
Installment
Nov. 30, 2015
USD ($)
Feb. 28, 2015
USD ($)
Nov. 30, 2014
USD ($)
Installment
Schedule of Equity Method Investments [Line Items]        
Equity in losses     $ (8,248)  
Saneron [Member]        
Schedule of Equity Method Investments [Line Items]        
Ownership interest 33.00% 33.00%    
Equity method investment $ 0 $ 0    
Impairment of investment in Saneron   $ 684,000    
Loan Saneron in quarterly payments an aggregate amount 300,000      
Initial loan amount $ 150,000      
Additional quarterly payments | Installment 0     5
Date of maturity 5 years      
First initial quarterly payment       $ 37,500
Saneron [Member] | Stock Awards [Member]        
Schedule of Equity Method Investments [Line Items]        
Equity in losses $ 0   $ 8,000  
Saneron [Member] | Initial Loan [Member]        
Schedule of Equity Method Investments [Line Items]        
Additional quarterly payments | Installment 4      
Quarterly installments per quarter $ 37,500      
Saneron [Member] | Additional Loan [Member]        
Schedule of Equity Method Investments [Line Items]        
Initial loan amount $ 150,000      
Additional quarterly payments | Installment 4      
Quarterly installments per quarter $ 37,500